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Carolina R. S. Elzinga1, Andrew J. Halayko3, Herman Meurs1,2, Harm Maarsingh4 and
Martina Schmidt1,2
1 Department of Molecular Pharmacology, University of Groningen, Groningen, Netherlands, 2 Groningen Research Institute
for Asthma and COPD, University Medical Center Groningen, University of Groningen, Groningen, Netherlands, 3 Department
of Physiology and Pathophysiology, University of Manitoba, Winnipeg, MB, Canada, 4 Department of Pharmaceutical
Sciences, Lloyd L. Gregory School of Pharmacy, Palm Beach Atlantic University, West Palm Beach, FL, United States
With the ability to switch between proliferative and contractile phenotype, airway smooth
muscle (ASM) cells can contribute to the progression of airway diseases such as asthma
and chronic obstructive pulmonary disease (COPD), in which airway obstruction is
associated with ASM hypertrophy and hypercontractility. A-kinase anchoring proteins
(AKAPs) have emerged as important regulatory molecules in various tissues, including
ASM cells. AKAPs can anchor the regulatory subunits of protein kinase A (PKA), and
guide cellular localization via various targeting domains. Here we investigated whether
disruption of the AKAP-PKA interaction, by the cell permeable peptide stearated (st)-
Ht31, alters human ASM proliferation and contractility. Treatment of human ASM with
st-Ht31 enhanced the expression of protein markers associated with cell proliferation
in both cultured cells and intact tissue, although this was not accompanied by
an increase in cell viability or cell-cycle progression, suggesting that disruption of
AKAP-PKA interaction on its own is not sufficient to drive ASM cell proliferation.
Strikingly, st-Ht31 enhanced contractile force generation in human ASM tissue with
concomitant upregulation of the contractile protein α-sm-actin. This upregulation of
α-sm-actin was independent of mRNA stability, transcription or translation, but was
dependent on proteasome function, as the proteasome inhibitor MG-132 prevented
the st-Ht31 effect. Collectively, the AKAP-PKA interaction appears to regulate markers
of the multi-functional capabilities of ASM, and this alter the physiological function,
such as contractility, suggesting potential to contribute to the pathophysiology of
airway diseases.
Keywords: airway smooth muscle, A-kinase anchoring proteins (AKAP), protein kinase A (PKA), asthma, chronic
obstructive pulmonary disease (COPD)
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INTRODUCTION
Airway smooth muscle (ASM) cells are phenotypic plastic, being
able to switch between a more proliferative (and less contractile)
or a more contractile (and less proliferative) state in response
to mitogens, growth factors (e.g., transforming growth factor-β),
and/or alterations in extracellular matrix composition (Halayko
et al., 2008). Phenotypic plasticity of ASM plays an important role
in the pathophysiology of obstructive pulmonary diseases, such
as chronic obstructive pulmonary disease (COPD) and asthma,
by enabling airway hypercontractility and ASM hypertrophy
and hyperplasia (Halayko et al., 2008), which both contribute
to airway narrowing and airflow limitation (Amrani and
Panettieri, 2003; Chung, 2005). The hypercontractile phenotype
is characterized by an increased expression of contractile
proteins, including α-smooth muscle actin (SMA) and calponin
(Halayko et al., 2008). We have previously shown that cyclic
adenosine monophosphate (cAMP) regulates mitogen-induced
phenotypic plasticity (Roscioni et al., 2011a,c). Furthermore,
activation of the cAMP effector protein kinase A (PKA) prevents
mitogen-induced proliferation by blunting the activation of
extracellular regulated kinase 1/2 (ERK1/2) and p70 ribosomal
protein S6 kinase (p70S6K), as well as inhibits mitogen-induced
reduction in contractile protein expression in ASM strips
(Roscioni et al., 2011a,c).
A-kinase anchoring proteins (AKAPs) are scaffolding proteins
that provide a molecular platform for other proteins to ensure
that signaling effectors are appropriately targeted to different
domains, thereby specifying and facilitating intracellular signal
transduction (Wong and Scott, 2004). Several AKAP isoforms
have been identified that can differ in their cellular localization
and interaction partners (Skroblin et al., 2010). A unifying feature
of AKAPs is their ability to anchor the regulatory subunits of
PKA in proximity to substrates via a conserved short α-helical
structure. A cell permeable inhibitor peptide, stearated (st)-Ht31,
was developed based on this short α-helical structure to block the
interaction between all members of the AKAP family and PKA.
St-Ht31 is designed in such a way that it specifically inhibits the
interaction between the RII subunits of cAMP-dependent PKA
and AKAPs. The sequence of st-Ht31 (24 amino acids) is derived
from endogenously expressed, human thyroid RII anchoring
protein Ht31 (Pawson and Scott, 1997; Vijayaraghavan et al.,
1997; Esseltine and Scott, 2013; Poppinga et al., 2014).
AKAPs are important in compartmentalizing cAMP within
the cellular context, thus providing spatio-temporal regulation
of the cAMP pathway (Wong and Scott, 2004). Due to the
ability of AKAPs to interact with the β2-adrenoceptor and
phosphodiesterases, these are important considerations, as β2-
agonists and phosphodiesterase inhibitors are commonly used
cAMP-elevating drugs for the treatment of respiratory disease
(Poppinga et al., 2014).
On this basis, AKAPs regulate a number of cellular responses
including intracellular actin dynamics and cell cycle progression
(Kim et al., 2013; Han et al., 2015). Cell cycle kinetics is controlled
by various effectors, including p70S6K, ERK1/2, proliferating
cell nuclear antigen (PCNA), cyclins, and retinoblastoma
protein (Rb) (Leonardi et al., 1992; Karpova et al., 1997;
Grewe et al., 1999; Bertoli et al., 2013; Dick and Rubin, 2013).
Most of these effectors can interact with AKAPs and dysfunction
of AKAPs is associated with cell cycle dysregulation (Akakura
et al., 2008; Pellagatti et al., 2010; Kong et al., 2013; Han et al.,
2015; Petrilli and Fernández-Valle, 2016). For instance, AKAP8
(also known as AKAP95), which is expressed in human ASM,
can interact with the cell cycle regulator cyclin D1 (Arsenijevic
et al., 2004; Horvat et al., 2012; Poppinga et al., 2015). However,
the overall role for AKAPs in regulating cell cycle transition and
contractility in human ASM is yet to be defined. Using the specific
AKAP-PKA interaction disruptor, st-Ht31 (Skroblin et al., 2010),
the current study explores the role of AKAPs in regulating
human ASM phenotypic modulation. Here we demonstrate
that disruption of AKAP-PKA interactions specifically alters the
phosphorylation status or expression of a subset of cell cycle
regulatory proteins in human ASM cells, which is unexpectedly
paralleled by hypercontractility in human bronchial strips.
MATERIALS AND METHODS
Cell Culture
Human ASM cell cultures were generated from macroscopically
healthy 3rd–5th generation bronchial segments obtained from
three different donors undergoing lung resection surgery,
and thereafter low passage number primary cultures (P2–P3)
were made senescence-resistant by stable ectopic expression of
human telomerase reverse transcriptase (hTERT) as described
previously (Gosens et al., 2006; Burgess et al., 2018). Primary
human ASM cells were isolated from human tracheal sections
from anonymized lung transplantation donors (obtained
from the Department of Cardiothoracic Surgery, University
Medical Center Groningen) as previously described (Roscioni
et al., 2011b). Cell cultures were maintained in DMEM (Life
technologies, 11965-092) containing heat-inactivated fetal
bovine serum (10% vol/vol), streptomycin (50 U/ml) and
penicillin (50 mg/ml) in a humidified atmosphere at 37◦C
in air/CO2 (95%:5% vol/vol). hTERT ASM cultures up to
passage 30 were used.
[3H]-Thymidine Incorporation Assay
hTERT ASM cells were plated in 24-well plates at 20,000
cells/well. After growing to confluence, cells were serum deprived
for 3 days and subsequently incubated with 50 µM st-Ht31
(V8211, Promega) or vehicle (i.e., water) for 4 h, then incubated
in the presence of [3H]-thymidine (0.25 µCi/ml) for 24 h.
After incubation, cells were washed twice with PBS at room
temperature and subsequently with ice-cold 5% trichloroacetic
acid on ice for 30 min and the acid-insoluble fraction was
dissolved in 1 ml NaOH (1 M). Incorporated [3H]-thymidine
was quantified by liquid-scintillation counting using a Beckam
LS1701 β-counter as described previously (Roscioni et al., 2011a).
Cell Viability Assay
hTERT ASM cells were plated in 24-well plates at 20,000 cells/well
and serum deprived for 3 days. Subsequently the cells were
incubated with st-Ht31 (50 µM) or vehicle for 24 h, after which
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the cells were washed twice with PBS and incubated with 5%
vol/vol AlamarBlue R© (DAL1100, Thermo Fisher Scientific) in
HBSS for 45 min. AlamarBlue R© is converted into its fluorescent
form by mitochondrial cytochromes in viable cells. Therefore,
the amount of fluorescence is proportional to the number of
living cells. Cell viability was assessed by measuring fluorescence




To study the effect of st-Ht31 on cell cycle distribution,
fluorescence-activated cell sorting (FACS) analysis was
performed in the hTERT ASM cells. hTERT ASM cells were
plated in 6-well plates at 200,000 cells/well. After growing
to confluence, cells were serum deprived for 3 days and
subsequently treated with st-Ht31 (50 µM) or vehicle for 24 h.
After incubation, cells were detached by trypsin treatment
and washed twice with warm PBS (37◦C). Cells were then
resuspended in ice-cold PBS and subsequently fixed in ice-cold
70% ethanol. After centrifugation, the cell pellet was resuspended
in PBS containing 10 µg/ml propidium iodide, 20 mM EDTA,
0.05% Tween 20 and 50 µg/ml RNAse, and incubated overnight
at 4◦C. Cell cycle analysis was performed on a BD FACSCalibur
(Becton, Dickinson and Company, BD, Franklin Lakes, NJ,
United States). Fluorescence histograms were collected for
at least 10,000 cells. The cell cycle distribution was analyzed
using ModFit LT flow cytometry modeling software (ModFit
LT, version 4.0.5).
Western Blot
hTERT ASM cells were plated in 6-well plates at 200,000
cells/well. After serum deprivation for 3 days, cells were treated
with st-Ht31 (50 µM) for 24 h. To study the possible mechanisms
underlying the effect of st-Ht31 on α-SMA and calponin protein
expressions, inhibitors (MG-132: 5 µM, ab141003, Abcam;
cycloheximide: 5 mg/ml, 44189, BDH Biochemicals; actinomycin
D: 1 µg/ml, A1410, Sigma; chloroquine diphosphate salt: 50 µM,
C6628, Sigma) were added for the final 24 h. After washing
twice with ice-cold PBS, cells were lysed using 100 µl of RIPA
buffer (composition: 50 mM Tris, 150 mM NaCl, 0.1% SDS, 0.5%
sodium deoxycholate, 1% nonyl phenoxypolyethoxylethanol),
supplemented with 1 mM Na3VO4, 1 mM NaF, 1,06 mg/ml
β-glycerolphosphate, 1 µg/ml apoprotein, 1 µg/ml leupeptin, and
1 µg/ml pepstatin A. The cell lysate was homogenized by passing
through a 25-gauge needle for 10 times. Protein content was
determined using the Pierce BCA protein assay.
Equal amounts of protein were prepared for SDS-PAGE
by adding 4X SDS loading buffer and ultrapure water, and
separated on a 10% polyacrylamide gel and transferred to
a nitrocellulose membrane, followed by blocking with 1x
Roti R©-Block (A151, Carl Roth), and incubated overnight with
primary antibodies (see Table 1). After washing, the membranes
were incubated with horseradish peroxidase-labeled secondary
antibodies (see Table 1). Protein bands were visualized using
Western Lightning R© Plus-ECL (NEL104001EA, PerkinElmer)
TABLE 1 | Antibodies used for Western blot analysis.
Protein of interest Primary antibody Secondary antibody
α-sm-actin 1:1000, A2547, Sigma 1:2000, A9044, Sigma
Calponin 1:1000, C2687, Sigma 1:5000, A9044, Sigma
PCNA 1:1000, sc-7907, Santa-Cruz 1:2000, A0545, Sigma
Pan-ubiquitin 1:1000, ab7780, Abcam 1:3000, A0545, Sigma
Cyclin D1 1:1000, #2926, Cell Signaling 1:1000, A9044, Sigma











1:2000, #9102, Cell Signaling 1:5000, A0545, Sigma
Caveolin-1 1:1000, sc-894 (HRP
conjugated), Santa-Cruz
Directly labeled




and quantified using ImageJ J 1.48v. Proteins were normalized to
GAPDH, lamin A/C, total ERK1/2 (p44/42 MAPK) or caveolin-
1, as appropriate.
Immunofluorescence
Primary human ASM cells or immortalized hTERT ASM cells
were plated at a density of 20,000 cells per well on a 24-well
plate with cover slips placed at the bottom of each well. Cells
were serum deprived for 3 days and subsequently treated with
st-Ht31 (50 µM) or vehicle for 24 h. After stimulation, cells
were washed twice with PBS and fixed with 4% paraformaldehyde
+ 4% sucrose for 15 min, followed by 0.3% Triton X100 for
2 min at room temperature. Cells were blocked with a blocking
buffer containing 5% bovine serum albumin (BSA) and 2%
donkey serum at room temperature for 1 h. After fixing, cells
were incubated overnight at 4◦C with the primary antibody
(α-sm-actin: 1:1000, A2547, Sigma; cyclin D1: 1:100, #2926,
Cell Signaling; AKAP8: 1:50, sc-10766, Santa-Cruz) diluted
in 1% BSA. The next day, after thorough wash, cells were
incubated with the secondary antibody (anti-rabbit FITC, Green,
1:500, 65-6111, Thermo Fisher Scientific) for 1 h at room
temperature in a dark chamber. After a thorough wash, nuclei
were stained with Hoechst (1:10,000, H3570, Invitrogen) for
5–10 s, immediately followed by two quick and four 10 min
washing steps with dd-H2O. Finally, cover slips were placed
and attached on microscope slides using ProLong Gold antifade
reagent (Invitrogen). Images were taken and analyzed using an
Olympus AX70 microscope equipped with digital image capture
system (ColorView Soft System with Olympus U CMAD2 lens,
Olympus Corporation, Tokyo, Japan). The background corrected
fluorescence measurements were performed with Image J 1.48v as
previously described (Burgess et al., 2010).
mRNA Isolation and Real Time PCR
hTERT ASM cells were plated in 6-well plates at a concentration
of 200,000 cells/well. After serum deprivation (1 day for actin
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alpha 2 (Acta2), calponin 1 (Cnn1), and 3 days for AKAP8), cells
were treated with st-Ht31 (50 µM) for 10 h. To determine the
half-life of ACTA2 mRNA, hTERT ASM cells were pretreated
with Actinomycin D (4 µM) 30 min prior to treatment with
st-Ht31 (50 µM) or vehicle for various time-points up to
24 h. mRNA from hTERT ASM cells was extracted using a
Nucleospin RNA II kit (Machery Nagel) and quantified using
spectrophotometry (NanoDrop, Thermo Fisher Scientific). 1 µg
of mRNA was converted into cDNA by reverse transcriptase
using Promega tools (Madison). cDNA was subjected to real-
time PCR (RT-PCR) using a MyiQTM Single-Color detection
system (Bio-Rad Laboratories Inc. Life Science Group) and
the specific primers (see Table 2). RT-qPCR was performed
in duplicate using SYBR Green (Roche) with denaturation at
94◦C for 30 s, annealing at 59◦C for 30 s and extension at
72◦C for 30 s for 40 cycles followed by 10 min at 72◦C. The
amount of target gene was normalized to ribosomal subunit 18 S
(designated as 1CT). Relative differences were determined using
the equation 2−(11Ct).
Human Tracheal Smooth Muscle Strips
Human tracheal tissue from anonymized lung transplantation
donors was obtained from the Department of Cardiothoracic
Surgery, University Medical Center Groningen. All tissue was
collected according to the Research Code of the University
Medical Center Groningen1 and national ethical and professional
guidelines (“Code of conduct,” Dutch federation of biomedical
scientific societies2). After dissection of the smooth muscle layer
and careful removal of the mucosa and connective tissue, human
tracheal smooth muscle strips of identical length and width
were prepared as described previously (Roscioni et al., 2011c).
The average weight of the bronchial strips is 13.9 ± 5.9 mg
(average ± standard deviation, n = 55). The main difference in
weight is due to interindividual differences between tissue of the
donors, rather than between bronchial strips derived from the
same donor. For each experiment, we randomize the prepared
bronchial strips before subsequent treatment is started. To limit
the possibility of variations between tissue preparations of the
same donor, we perform each experiment at least in duplicate and




TABLE 2 | primers used for qRT-PCR.









is considered as one independent data-point. Tissue strips were
transferred to serum-free DMEM supplemented with sodium
pyruvate (1 mM), non-essential amino acid mixture (1:100),
gentamicin (45 µg/ml), penicillin (100 U/ml), streptomycin (100
µg/ml), amphotericin B (1.5 µg/ml), apo-transferrin (human, 5
µg/ml) and ascorbic acid (100 µM). The strips were incubated
with st-Ht31 (50 µM) or vehicle for 24 h in an Innova 4000
incubator shaker (37◦C, 55 rpm). After culture, strips were
thoroughly washed and mounted in an organ bath for isometric
tension measurements.
Isometric Contraction Measurement
Isometric contraction experiments were performed essentially
as described previously (Roscioni et al., 2011c). Briefly, ASM
strips were mounted for isometric recording in 20 ml organ-
baths, containing Krebs-Henseleit (composition in mM: NaCl
117.5, KCl 5.60, MgSO4 1.18, CaCl2 2.50, NaH2PO4 1.28,
NaHCO3 25.00, and glucose 5.50) buffer at 37◦C. During a
90 min equilibration period with wash-outs every 30 min, resting
tension was adjusted to 1 g, followed by pre-contractions with
10 µM methacholine. Following wash-out, maximal relaxation
was established by the addition of 0.1 µM (-)-isoprenaline.
Tension was readjusted to 1 g, followed by refreshing of
the Krebs-Henseleit buffer twice. After another equilibration
period of 30 min, cumulative concentration–response curves
were constructed with methacholine (0.1 nM – 1 mM). When
maximal tension was reached, strips were washed several times
and maximal relaxation was established using 10 µM (-)-
isoproterenol. Contractions were corrected for tissue weight and
expressed as percentage of the maximal methacholine-induced
contraction in vehicle-treated strips. Curves were fitted using
Prism 5.0. After the contraction protocol, strips were collected
and tissue homogenates were prepared as previously described
(Roscioni et al., 2011c) for western blot measurement of α-sm-
actin, calponin and PCNA.
Statistics
Data are expressed as means± SEM of n individual experiments.
Statistical significance of differences was evaluated using Prism
5.0 software by performing One-sample T-tests. For the isometric
contraction experiments: non-linear curve fit was performed and
subsequent statistical curve comparison was done using the extra
sum-of-squares F-test using Prism 5.0 software. Differences were
considered to be statistically significant when p < 0.05.
RESULTS
Role of AKAPs in Proliferation of Human
ASM Cells
Treatment with st-Ht31 significantly increased [3H]-thymidine
incorporation in hTERT ASM cells (Figure 1A), indicating
enhanced DNA synthesis. However, st-Ht31 treatment for 4 days
did not affect cell viability (Figure 1B). We further assessed cell
cycle distribution of propidium iodide stained hTERT ASM cells
by flow cytometry and found that st-Ht31 exposure had little
effect (Figure 1C).
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FIGURE 1 | The effects of st-Ht31 on proliferation markers in human airway smooth muscle cells. hTERT ASM cells were serum-deprived for 3 days and treated with
st-Ht31 (50 µM). (A) [3H]-thymidine was added 4h after st-Ht31 and incorporated [3H]-thymidine was quantified 2 4h later. n = 15. (B) After 24h of treatment with
st-Ht31, cell viability was assessed using AlamarBlue R©. n = 5. (C) FACS analysis was performed 24 h after st-Ht31 treatment. n = 3. (D–H) Protein expression of the
indicated proteins was measured 24 h after st-Ht31 treatment using Western blot (D–G) or immunofluorescence (IF, H). n = 4–9. *p < 0.05, **p < 0.05, and
***p < 0.001 compared to basal.
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To further understand the paradoxical increase in DNA
synthesis without cell cycle induction with st-Ht31 treatment, we
investigated the abundance and phosphorylation status of cell
cycle regulator proteins. Treatment of hTERT ASM cells with
st-Ht31 enhanced the phosphorylation status of the cell-cycle
regulators Rb and p70S60K, without affecting ERK1/2 (p42/44
MAPK) phosphorylation (Figures 1D–F). Moreover, st-Ht31
treatment increased cyclin D1 abundance in hTERT ASM cells
(Figures 1G,H).
AKAP8 Expression and Localization in
Human ASM Cells
Previous studies by us and others demonstrated protein and/or
mRNA expression of a subset of AKAPs in human ASM,
including AKAP1, AKAP2, AKAP3, AKAP5 (also known
as AKAP79), AKAP8, AKAP9, AKAP10, AKAP11, AKAP12,
AKAP13, Ezrin, and MAP2B (Horvat et al., 2012; Poppinga et al.,
2015). We currently investigated the effect of st-Ht31 on the
expression of AKAP8, as this particular AKAP is associated with
cell cycle progression (Han et al., 2015). Treatment of hTERT
ASM cells with st-Ht31 decreased the fluorescent intensity of total
AKAP8 compared to vehicle treated cells (Figure 2A). The ratio
of the cellular distribution of AKAP8 between nuclei and non-
nuclear compartments was not altered by st-Ht31, indicating that
st-Ht31 causes a general decrease in AKAP8 abundance. In line
with the changes in protein level, we found that st-Ht31 also
significantly decreased AKAP8 mRNA expression (Figure 2B).
Besides AKAP8, we also measured the expression of AKAP5,
AKAP12, and Ezrin, but none were significantly altered by st-
Ht31 (data not shown). Primary human ASM cells also showed
decreased AKAP8 expression, without an effect on its cellular
distribution, in response to st-Ht31 (Figure 2C).
Role of AKAPs in Contractile Protein
Expression in Human ASM Cells
Treatment of hTERT ASM cells with st-Ht31 resulted in a
significant increase in the abundance of the contractile proteins
α-sm-actin and calponin (Figures 3A,B). Remarkably, the mRNA
abundance for ACTA2 and CNN1 (encoding α-sm-actin and
calponin, respectively) was decreased (i.e., ACTA2) or unaltered
(i.e., CNN1) in response to st-Ht31 (Figure 3C). Next, we
investigated if disruption of the AKAP-PKA interaction in
human ASM cells by st-Ht31 affected mRNA stability of ACTA2.
Expression of ACTA2 decreased over time in human ASM cells
and this process was unaffected by st-Ht31 (Figure 3D).
To investigate the potential mechanism(s) for the differential
effects of st-Ht31 on mRNA and protein abundance of
contractile proteins α-sm-actin and calponin, we independently
inhibited gene transcription, translation, and protein degradation
using pharmacological tools. Inhibition of RNA synthesis by
actinomycin D decreased basal and st-Ht31-induced α-sm-
actin and calponin protein abundance in human ASM cells
(Figures 4A,B). However, compared directly to time-matched
actinomycin D treated cultures, the addition of st-Ht31 still
increased sm-α-actin and calponin abundance in human
ASM cells (Figures 4A,B). Cycloheximide, an inhibitor of
protein synthesis, did not affect (α-sm-actin) or even enhanced
(calponin) contractile protein abundance in the presence or
absence of st-Ht31 (Figures 4A,B). Pharmacological suppression
of protein degradation with the proteasome inhibitor MG-132,
was without major effect on basal abundance of sm-α-actin and
calponin, but prevented the induction of α-sm-actin by st-Ht31
(Figures 4A,B). Concomitant, we observed a transient increase
in ubiquitination of a variety of proteins in response to short-
term st-Ht31 treatment (Figure 4C). Finally, inhibition of protein
turnover by targeting lysosomal enzymes with chloroquine did
not affect contractile protein abundance at baseline or after
treatment with st-Ht31 (Figures 4A,B).
Role of AKAPs in Regulating
Contractility and Proliferation in Human
Bronchial Strips
To investigate the functional consequence of increased
contractile protein abundance that we observed in cultured
ASM cells, we incubated human ASM tissue strips with st-Ht31
and subsequently assessed methacholine-induced isometric
contraction. Treatment with st-Ht31 significantly increased
contraction by 1.3-fold (Emax; Figure 5A), without affecting
the sensitivity to methacholine (pD2-values: 5.28 ± 0.18
and 5.36 ± 0.18 for basal and st-Ht31 treated, respectively).
The increased capacity to generate (maximum) force was
accompanied by a concomitant increase in α-sm-actin protein
abundance (Figure 5B), whereas calponin expression showed
more variation and was not significantly altered (data not
shown). Furthermore, treatment of human ASM strips with st-
Ht31 resulted in an increase in the S-phase marker proliferating
cell nuclear antigen (PCNA) (Figure 5C).
DISCUSSION
We demonstrate that disruption of AKAP-PKA interactions
using st-Ht31 increases expression of the contractile proteins
α-sm-actin and calponin in human ASM cells, and development
of hypercontractile human ASM in bronchial strips. In parallel,
st-Ht31 enhances DNA synthesis and expression of markers
for ASM cell proliferation, although neither cell viability nor
cell cycle distribution are affected directly. Collectively, these
findings indicate that AKAP-PKA mediated signaling regulates
ASM phenotype and function.
AKAPs are a group of structurally diverse proteins, which act
as scaffolds for a variety of structural and signaling molecules to
facilitate targeting of different cellular microdomains (Wong and
Scott, 2004; Poppinga et al., 2014). We recently demonstrated that
the expression of several AKAPs in ASM and bronchial epithelial
cells is differentially affected by cigarette smoke (Oldenburger
et al., 2014; Poppinga et al., 2015). Moreover, we observed
differential expression of AKAPs in lung tissue of COPD patients
(Oldenburger et al., 2014; Poppinga et al., 2015). All AKAPs
combine with the regulatory subunits of PKA through a short
α-helical structure to guide activity in different sub-cellular
locales (Esseltine and Scott, 2013). This functional feature was
exploited in the development of the st-Ht31 peptide, as it
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FIGURE 2 | The effects of st-Ht31 on AKAP8 expression and cellular localization in human airway smooth muscle cells. (A) hTERT ASM cells were serum deprived
for 3 days and treated with st-Ht31 (50 µM) for 24 h. The expression and localization of AKAP8 was measured by immunofluorescence. Representative images are
shown. Images were quantified by Image J 1.48v. n = 4. (B) AKAP8 mRNA expression was measured in hTERT ASM cells using RT-PCR and normalized to
ribosomal subunit 18 S (1CT). Relative differences were determined using the equation 2−(11Ct). n = 4. (C) Primary human ASM cells were serum deprived for 3
days and treated with st-Ht31 (50 µM) for 24 h. The expression and localization of AKAP8 were measured by immunofluorescence. Representative images are
shown. Images were quantified by Image J 1.48v. N = 5, *p < 0.05 and **p < 0.01 compared to basal.
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FIGURE 3 | The effect of st-Ht3 on contractile markers in human airway smooth muscle cells. (A,B) hTERT ASM cells were serum deprived for 3 days and treated
with st-Ht31 (50 µM) for 24 h. Protein expression of α-sm-actin (A,B) and calponin (A) were measured by western blot (A) or immunofluorescence (IF, B). Data
expressed as means ± SEM of n = 5–8. (C) hTERT ASM cells were serum deprived for 1 day and treated with st-Ht31 (50 µM) for 1 h. ACTA2 and CNN1
expression was measured using RT-PCR and normalized to ribosomal subunit 18 S (1CT). Relative differences were determined using the equation 2−(11Ct). n = 4.
(D) hTERT ASM cells were pretreated with actinomycin D (4 µM) and subsequently treated without (control) or with st-Ht31 (50 µM) for the indicated time-points.
ACTA2 expression was measured using RT-PCR and normalized to ribosomal subunit 18 S (1CT). Relative differences were determined using the equation
2−(11Ct). n = 6. *p < 0.05 and **p < 0.01 compared to basal.
mimics the short α helical structure in AKAPs, to competitively
block AKAP interaction with PKA (Vijayaraghavan et al., 1997).
However, stimulus-induced PKA activation in human ASM is not
affected by st-Ht31 (Poppinga et al., 2015). Since its development,
st-Ht31 has been shown to alter a variety of cellular functions,
including cardiac muscle contraction and cell cycle progression
(McConnell et al., 2009; Gao et al., 2012).
ASM cells exhibit phenotype plasticity, which allows
modulation of contractile and proliferative functional capacity
in response to changes in the surrounding microenvironment
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FIGURE 4 | Potential mechanisms underlying st-Ht31-induced contractile protein expression in human airway smooth muscle cells. (A,B) hTERT ASM cells were
treated with st-Ht31 (50 µM) in the absence or presence of actinomycin D (1 µg/ml), cycloheximide (5 mg/ml), MG-132 (5 µM) and chloroquine (50 µM). Protein
expression of α-sm-actin and calponin was analyzed and quantified. n = 5–8 experiments. (C) hTERT ASM cells were treated with vehicle or st-Ht31 (50 µM) for 1h.
The degree of protein ubiquitination in whole cell lysate was detected using an anti-ubiquitin antibody. *p < 0.05, **p < 0.01, and ***p < 0.001 compared to vehicle
without st-Ht31, #p < 0.05 and ###p < 0.001 compared to vehicle with st-Ht31.
(Halayko et al., 2008). Prolonged exposure to mitogens
induces a hyperproliferative, hypocontractile ASM phenotype,
characterized by increased DNA synthesis and mitosis, as well
as reduced contractile protein abundance (Halayko et al., 2008;
Simeone-Penney et al., 2008; Roscioni et al., 2011a,c). On
the other hand, other stimuli such as transforming growth
factor-β1 (TGF-β1), insulin or changes in extracellular laminin
composition can induce a hypoproliferative, hypercontractile
ASM phenotype (Ma et al., 1998; Gosens et al., 2003; Schaafsma
et al., 2007; Halayko et al., 2008; Dekkers et al., 2009; Tran et al.,
2013, Ojiaku et al., 2018). Interestingly, we now demonstrate
that interrupting the interaction between PKA and AKAPs
simultaneously increases markers of a hyperproliferative
(e.g., DNA synthesis, activation of cell cycle proteins and
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FIGURE 5 | The effects of st-Ht31 on contraction of human airway smooth
muscle strips. Isolated human tracheal smooth muscle strips were incubated
without or with st-Ht31 (50 µM). (A) Methacholine-induced isometric
contraction was measured. N = 7–8. ***p < 0.001 compared to basal as
determined by an extra sum-of-squares F-test. (B,C) The expression of
α-sm-actin (B) and PCNA (C) was determined in the tracheal strips by
immunoblotting. N = 4–5, *p < 0.05 compared to basal.
increased expression of the proliferative marker PCNA) and
a hypercontractile phenotype (e.g., increased expression of
contractile proteins and increased contractility) in cultured
human ASM cells and in intact human ASM strips.
A potential modulator of ASM phenotype is p70 ribosomal
S6 kinase (p70S6K) (Halayko et al., 2004; Roscioni et al., 2011a).
Mitogen exposure of human ASM cells leads to phosphorylation
and activation of p70 ribosomal S6 kinase (p70S6K), which
promotes cell proliferation via upregulation of various proteins,
including the cell-cycle checkpoint determinant cyclin D1 (Scott
et al., 1996; Karpova et al., 1997; Grewe et al., 1999; Takuwa
et al., 1999; Ravenhall et al., 2000; Chambard et al., 2007;
Roscioni et al., 2011b). We have previously demonstrated that
p70S6K phosphorylation reduced by activation of PKA (Roscioni
et al., 2011a). Disruption of the AKAP-PKA interaction by
st-Ht31 leads to a loss of intracellular targeting of PKA,
which, however, is not accompanied by a loss of PKA activity
(Poppinga et al., 2015). Although PKA can still be activated,
it cannot signal properly in a spatiotemporal manner in the
presence of st-Ht31. In the current study, we observed an
enhanced p70S6K phosphorylation and increased Cyclin D1
expression in human ASM in response to st-Ht31, without an
effect on ERK1/2 activity. Cyclin D1 associates with pre-existing
cyclin-dependent kinases to phosphorylate target proteins, such
as Rb, that further enable and modulate cell cycle progress
into S phase (Lundberg and Weinberg, 1998). In agreement, st-
HT31 concomitantly increases phosphorylation of Rb and DNA
synthesis (Withers et al., 1997; Takuwa et al., 1999). Moreover,
in intact human bronchial strips st-Ht31 treatment resulted in
increased PCNA expression, a protein that is expressed during
the S phase of the cell cycle (Leonardi et al., 1992). Nonetheless,
the st-HT31-induced DNA synthesis was not accompanied by
a change in cell cycle distribution nor by an alteration of
cell viability, suggesting that disruption of the AKAP-PKA
interaction is not sufficient on its own to induce cells to traverse
the S phase of the cell cycle. Our FACS analysis in human
ASM cells confirm that st-Ht31 has no significant impact on the
fraction of cells in the S phase. Interestingly, AKAPs, particularly
AKAP8, interact with cyclins, including cyclin D1 (Eide et al.,
1998; Arsenijevic et al., 2004; Han et al., 2015; Qi et al., 2015).
AKAP8 can reside in the nucleus, as confirmed by our study,
and is thought to be involved in DNA replication and expression
of several genes associated with cell cycle regulation (Coghlan
et al., 1994; Eide et al., 1998; Han et al., 2015). An AKAP8-cyclin
D binding site has been identified that overlaps with a CDK4
binding site, suggesting that nuclear AKAP8 may compete with
CDK4 for cyclin D1 (Arsenijevic et al., 2006). Therefore, the
observed downregulation of AKAP8 by st-Ht31 in ASM cells,
without alterations in cellular distribution, could be permissive
for interaction of cyclin D1 with CDK4, thereby supporting
Rb phosphorylation and early S phase activities. On the other
hand, AKAP8 has been found to regulate M phase events of the
cell cycle, such as chromatin condensation, by interacting with
DNA and associated proteins including a condensin complex
component, Eg7 and histone deacetylase 3 (Collas et al., 1999;
Steen et al., 2000; Li et al., 2006). Based on this, and in light of our
observations, we hypothesize that, in addition to disrupting the
interactions between AKAPs and PKA, st-Ht31-induced AKAP8
downregulation could contribute to disturbed cell cycle kinetics,
that in our studies are revealed by increased proliferative markers
without an increase in cell number.
Another interesting observation from our study is that
disruption of the AKAP-PKA interaction by st-HT31 increases
contractile protein expression in human ASM. However, st-
Ht31 had little or no effect on CNN1 expression and even
decreased ACTA2 expression. Our results also demonstrate that
st-Ht31 does not affect mRNA stability of ACTA2. Furthermore,
blocking of RNA synthesis by actinomycin D decreased both
basal and st-HT31-induced protein abundance of α-sm-actin and
calponin. However, compared to solely actinomycin D treatment
addition of st-Ht31 still induced an increase in contractile
protein expression in human ASM cell. This suggests that
the effects of st-Ht31 are, in part, due to post-translational
effects. This is confirmed by our observation that inhibition of
protein translation using cycloheximide did not affect st-Ht31-
induced contractile protein accumulation. Recently, AKAPs
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have been identified as factors involved in protein turnover,
specifically involved with ubiquitin-proteasome systems that tag
substrate proteins for subsequent degradation by the covalent
attachment of ubiquitin (Rinaldi et al., 2015). This system
involves modification of substrate proteins by the covalent
attachment of multiple ubiquitin molecules. Ubiquitination is
a post-translational modification that generally directs proteins
for degradation by the proteasome. However, ubiquitination
has also been implicated in many other cellular processes,
including transcriptional regulation (Ciechanover, 2005; Stringer
and Piper, 2011). We show that treatment of human ASM
with the proteasome inhibitor MG-132 prevents st-Ht31-induced
α-sm-actin accumulation. In agreement, in vascular smooth
muscle cells MG-132 reduces contractile protein expression by
reducing myocardin activation (Yin et al., 2011). Myocardin
and myocardin related transcription factors (MRTFs) are
transcriptional co-activators of serum response factor (SRF),
a master regulator of α-smooth muscle actin. In cardiac
myofibroblasts, α-sm-actin expression is linked to AKAP-Lbc
(also known as AKAP13) by its regulatory effects on myocardin
related transcription factors (MRTFs) (Cavin et al., 2014). Clearly,
future studies are necessary to investigate the effects of st-HT31 as
a potential regulator of myocardin and/or MRTF activation and
subsequent contractile protein expression in human ASM cells.
Most importantly, our functional analyses demonstrated
increased contraction of human bronchial strips after st-Ht31
treatment. This hypercontractile ASM phenotype is accompanied
by increased abundance of α-sm-actin. Of note, the involvement
of AKAPs in muscle contraction has previously been shown in
the heart (McConnell et al., 2009). Similar to the findings in
cultured cells, st-Ht31 also increased a marker of proliferation,
i.e., PCNA, in ex vivo human bronchial strips. Thus, markers
of proliferation and contractility are simultaneously increased
in ASM tissue and cultured cells. However, st-Ht31 does not
alter cell viability in cultured cells, but does increase contractility
of intact human ASM tissue. These findings demonstrate the
importance of studying functional readouts for the different
phenotypes: cell proliferation and contractility. Thus, st-Ht31
may initially induce markers that could underpin modulation to
a proliferative phenotype. However, since it is insufficient to fully
induce cell cycle progression and proliferation, this appears to
trigger a response, either indirectly or in a mutually exclusive
manner, that leads to a later induction of a hypercontractile
phenotype. This hypothesis is supported by the finding that
insulin acutely induces DNA synthesis in cultured ASM cells,
but long-term treatment with insulin induces a hypercontractile
phenotype in intact ASM tissue (Gosens et al., 2003).
In summary, we show that st-Ht31 leads to a simultaneous
increase in markers of a hypercontractile phenotype and those of
a hyperproliferative phenotype in both ASM cells and intact ASM
strips. However, increased DNA synthesis and the activation
of early cell cycle regulators are not sufficient to complete
proliferation and increase cell number. In contrast, the increase
in contractile protein expression (marker of a hypercontractile
phenotype) did lead to an increase in contractility, indicating
the overall effect of disruption of AKAP-PKA interaction is the
induction of a hypercontractile phenotype. Previous studies from
our group and others, have reported on the expression of at least
12 AKAP family members in human ASM, which might be of
interest to target independently or all together by silencing and/or
Crisp/Cas9 technologies in future studies (Horvat et al., 2012;
Poppinga et al., 2015). In conclusion, AKAP-PKA interactions
in ASM cells and tissue limits the contractile function of
ASM, likely by restricting the expression of contractile proteins
and the development of a hyperproliferative phenotype. Our
observations have biological and drug development implications
in obstructive respiratory disease, such as asthma and COPD,
where there is both an increase in ASM mass and ASM
contractility (Lambert et al., 1993; Chung, 2005, 2008; Bentley
and Hershenson, 2008). The mechanisms of drugs used in
the treatment of respiratory disease, such as β2-agonists and
phosphodiesterase inhibitors, most likely encompass proper
AKAP-PKA interactions.
DATA AVAILABILITY STATEMENT
The datasets generated for this study are available on request to
the corresponding author.
ETHICS STATEMENT
All tissue was collected according to the Research Code of
the University Medical Center Groningen (https://www.
umcg.nl/SiteCollectionDocuments/English/Researchcode/
UMCG-Researchcode,%20basic%20principles%202013.pdf)
and national ethical and professional guidelines (“Code of
conduct,” Dutch federation of biomedical scientific societies,
http://www.federa.org). The patients/participants provided their
written informed consent to participate in this study.
AUTHOR CONTRIBUTIONS
BH, WP, SD, and CE designed and performed the experiments
and performed the data analyses. HB, HMe, HMa, and MS
designed the experiments and oversaw all data analyses. AH
provided immortalized human airway smooth muscle cells. HB,
BH, and MS drafted the figures and manuscript. All authors have
critically revised the manuscript, reviewed, and approved the final
manuscript as submitted to take public responsibility for it.
FUNDING
This study was supported by a grant of the Ubbo Emmius
Program of Faculty of Mathematics and Natural Sciences,
University of Groningen. WP was supported by a grant
from the Dutch Lung Foundation (3.2.11.15). MS was
supported by a Rosalind Franklin Fellowship from the
University of Groningen and a grant from the Deutsche
Forschungsgemeinschaft (IRTG1874/1). AH was supported by
the Canada Research Chairs Program.
Frontiers in Cell and Developmental Biology | www.frontiersin.org 11 April 2020 | Volume 8 | Article 165
fcell-08-00165 April 8, 2020 Time: 16:13 # 12
Baarsma et al. AKAP-PKA Interaction in Human ASM
REFERENCES
Akakura, S., Huang, C., Nelson, P. J., Foster, B., and Gelman, I. H. (2008). Loss of
the SSeCKS/Gravin/AKAP12 gene results in prostatic hyperplasia. Cancer Res.
6813, 5096–5103. doi: 10.1158/0008-5472.CAN-07-5619
Amrani, Y., and Panettieri, R. A. (2003). Airway smooth muscle: contraction and
beyond. Int. J. Biochem. Cell Biol. 353, 272–276.
Arsenijevic, T., Degraef, C., Dumont, J. E., Roger, P. P., and Pirson, I. (2004). A
novel partner for D-type cyclins: protein kinase A-anchoring protein AKAP95.
Biochem. J. 378(Pt 2), 673–679. doi: 10.1042/bj20031765
Arsenijevic, T., Degraef, C., Dumont, J. E., Roger, P. P., and Pirson, I. (2006). G1/S
Cyclins interact with regulatory subunit of PKA via A-kinase anchoring protein,
AKAP95. Cell Cycle 511, 1217–1222. doi: 10.4161/cc.5.11.2802
Bentley, J. K., and Hershenson, M. B. (2008). Airway smooth muscle growth in
asthma: proliferation, hypertrophy, and migration. Proc. Am. Thorac. Soc. 51,
89–96. doi: 10.1513/pats.200705-063vs
Bertoli, C., Skotheim, J. M., and de Bruin, R. A. (2013). Control of cell cycle
transcription during G1 and S phases. Nat. Rev. Mol. Cell Biol. 148, 518–528.
doi: 10.1038/nrm3629
Burgess, A., Vigneron, S., Brioudes, E., Labbe, J. C., Lorca, T., and Castro, A. (2010).
Loss of human Greatwall results in G2 arrest and multiple mitotic defects due
to deregulation of the cyclin B-Cdc2/PP2A balance. Proc. Natl. Acad. Sci. U.S.A.
10728, 12564–12569. doi: 10.1073/pnas.0914191107
Burgess, J. K., Ketheson, A., Faiz, A., Limbert Rempel, K. A., Oliver, B. G., Ward,
J. P. T., et al. (2018). Phenotype and functional features of human telomerase
reverse transcriptase immortalized human airway smooth muscle cells from
asthmatic and non-asthmatic donors. Sci. Rep. 8:805. doi: 10.1038/s41598-017-
18429-0
Cavin, S., Maric, D., and Diviani, D. (2014). A-kinase anchoring protein-Lbc
promotes pro-fibrotic signaling in cardiac fibroblasts. Biochim. Biophys. Acta
18432, 335–345. doi: 10.1016/j.bbamcr.2013.11.008
Chambard, J. C., Lefloch, R., Pouyssegur, J., and Lenormand, P. (2007). ERK
implication in cell cycle regulation. Biochim. Biophys. Acta 17738, 1299–1310.
doi: 10.1016/j.bbamcr.2006.11.010
Chung, K. F. (2005). The role of airway smooth muscle in the pathogenesis of
airway wall remodeling in chronic obstructive pulmonary disease. Proc. Am.
Thorac. Soc. 24, 347–354; discussion 371–372.
Chung, K. F. (2008). Airway Smooth Muscle in Asthma and COPD: Biology and
Pharmacology. Hoboken, NJ: John Wiley & Sons Ltd.
Ciechanover, A. (2005). Proteolysis: from the lysosome to ubiquitin and the
proteasome. Nat. Rev. Mol. Cell Biol. 61, 79–87. doi: 10.1038/nrm1552
Coghlan, V. M., Langeberg, L. K., Fernandez, A., Lamb, N. J., and Scott, J. D. (1994).
Cloning and characterization of AKAP 95, a nuclear protein that associates with
the regulatory subunit of type II cAMP-dependent protein kinase. J. Biol. Chem.
26910, 7658–7665.
Collas, P., Le Guellec, K., and Tasken, K. (1999). The A-kinase-anchoring protein
AKAP95 is a multivalent protein with a key role in chromatin condensation at
mitosis. J. Cell Biol. 1476, 1167–1180. doi: 10.1083/jcb.147.6.1167
Dekkers, B. G., Schaafsma, D., Tran, T., Zaagsma, J., and Meurs, H. (2009). Insulin-
induced laminin expression promotes a hypercontractile airway smooth muscle
phenotype. Am. J. Respir. Cell Mol. Biol. 414, 494–504. doi: 10.1165/rcmb.2008-
0251OC
Dick, F. A., and Rubin, S. M. (2013). Molecular mechanisms underlying RB protein
function. Nat. Rev. Mol. Cell Biol. 145, 297–306. doi: 10.1038/nrm3567
Eide, T., Coghlan, V., Orstavik, S., Holsve, C., Solberg, R., Skalhegg, B. S., et al.
(1998). Molecular cloning, chromosomal localization, and cell cycle-dependent
subcellular distribution of the A-kinase anchoring protein, AKAP95. Exp. Cell
Res. 2382, 305–316. doi: 10.1006/excr.1997.3855
Esseltine, J. L., and Scott, J. D. (2013). AKAP signaling complexes: pointing
towards the next generation of therapeutic targets? Trends Pharmacol. Sci. 3412,
648–655. doi: 10.1016/j.tips.2013.10.005
Gao, X., Chaturvedi, D., and Patel, T. B. (2012). Localization and retention of p90
ribosomal S6 kinase 1 in the nucleus: implications for its function. Mol. Biol.
Cell 233, 503–515. doi: 10.1091/mbc.E11-07-0658
Gosens, R., Nelemans, S. A., Hiemstra, M., Grootte Bromhaar, M. M., Meurs,
H., and Zaagsma, J. (2003). Insulin induces a hypercontractile airway smooth
muscle phenotype. Eur. J. Pharmacol. 4811, 125–131. doi: 10.1016/j.ejphar.
2003.08.081
Gosens, R., Stelmack, G. L., Dueck, G., McNeill, K. D., Yamasaki, A., Gerthoffer,
W. T., et al. (2006). Role of caveolin-1 in p42/p44 MAP kinase activation and
proliferation of human airway smooth muscle. Am. J. Physiol. Lung Cell. Mol.
Physiol. 2913, L523–L534.
Grewe, M., Gansauge, F., Schmid, R. M., Adler, G., and Seufferlein, T. (1999).
Regulation of cell growth and cyclin D1 expression by the constitutively active
FRAP-p70s6K pathway in human pancreatic cancer cells. Cancer Res. 5915,
3581–3587.
Halayko, A. J., Kartha, S., Stelmack, G. L., McConville, J., Tam, J., Camoretti-
Mercado, B., et al. (2004). Phophatidylinositol-3 kinase/mammalian target
of rapamycin/p70S6K regulates contractile protein accumulation in airway
myocyte differentiation. Am. J. Respir. Cell Mol. Biol. 313, 266–275. doi: 10.
1165/rcmb.2003-0272oc
Halayko, A. J., Tran, T., and Gosens, R. (2008). Phenotype and functional plasticity
of airway smooth muscle: role of caveolae and caveolins. Proc. Am. Thorac. Soc.
51, 80–88. doi: 10.1513/pats.200705-057vs
Han, B., Poppinga, W. J., and Schmidt, M. (2015). Scaffolding during the cell
cycle by A-kinase anchoring proteins. Pflugers Arch. 46712, 2401–2411. doi:
10.1007/s00424-015-1718-0
Horvat, S. J., Deshpande, D. A., Yan, H., Panettieri, R. A., Codina, J., DuBose,
T. D. Jr., et al. (2012). A-kinase anchoring proteins regulate compartmentalized
cAMP signaling in airway smooth muscle. FASEB J. 269, 3670–3679. doi: 10.
1096/fj.11-201020
Karpova, A. Y., Abe, M. K., Li, J., Liu, P. T., Rhee, J. M., Kuo, W. L., et al. (1997).
MEK1 is required for PDGF-induced ERK activation and DNA synthesis in
tracheal myocytes. Am. J. Physiol. 2723(Pt 1), L558–L565.
Kim, M., Kim, M., Lee, S., Kuninaka, S., Saya, H., Lee, H., et al. (2013). cAMP/PKA
signalling reinforces the LATS-YAP pathway to fully suppress YAP in response
to actin cytoskeletal changes. EMBO J. 3211, 1543–1555. doi: 10.1038/emboj.
2013.102
Kong, J., Li, Y., Liu, S., Jin, H., Shang, Y., Quan, C., et al. (2013). High expression
of ezrin predicts poor prognosis in uterine cervical cancer. BMC Cancer 13:520.
doi: 10.1186/1471-2407-13-520
Lambert, R. K., Wiggs, B. R., Kuwano, K., Hogg, J. C., and Pare, P. D. (1993).
Functional significance of increased airway smooth muscle in asthma and
COPD. J. Appl. Physiol. 746, 2771–2781.
Leonardi, E., Girlando, S., Serio, G., Mauri, F. A., Perrone, G., Scampini, S., et al.
(1992). PCNA and Ki67 expression in breast carcinoma: correlations with
clinical and biological variables. J. Clin. Pathol. 455, 416–419. doi: 10.1136/jcp.
45.5.416
Li, Y., Kao, G. D., Garcia, B. A., Shabanowitz, J., Hunt, D. F., Qin, J., et al.
(2006). A novel histone deacetylase pathway regulates mitosis by modulating
Aurora B kinase activity. Genes Dev. 2018, 2566–2579. doi: 10.1101/gad.145
5006
Lundberg, A. S., and Weinberg, R. A. (1998). Functional inactivation of the
retinoblastoma protein requires sequential modification by at least two distinct
cyclin-cdk complexes. Mol. Cell. Biol. 182, 753–761. doi: 10.1128/mcb.18.2.753
Ma, X., Wang, Y., and Stephens, N. L. (1998). Serum deprivation induces a unique
hypercontractile phenotype of cultured smooth muscle cells. Am. J. Physiol.
2745, C1206–C1214. doi: 10.1152/ajpcell.1998.274.5.C1206
McConnell, B. K., Popovic, Z., Mal, N., Lee, K., Bautista, J., Forudi, F., et al.
(2009). Disruption of protein kinase A interaction with A-kinase-anchoring
proteins in the heart in vivo: effects on cardiac contractility, protein kinase A
phosphorylation, and troponin I proteolysis. J. Biol. Chem. 2843, 1583–1592.
doi: 10.1074/jbc.M806321200
Ojiaku, C. A., Cao, G., Zhu, W., Yoo, E. J., Shumyatcher, M., Himes, B. E., et al.
(2018). TGF-beta1 evokes human airway smooth muscle cell shortening and
hyperresponsiveness via Smad3. Am. J. Respir. Cell Mol. Biol. 585, 575–584.
doi: 10.1165/rcmb.2017-0247OC
Oldenburger, A., Poppinga, W. J., Kos, F., de Bruin, H. G., Rijks, W. F., Heijink,
I. H., et al. (2014). A-kinase anchoring proteins contribute to loss of E-cadherin
and bronchial epithelial barrier by cigarette smoke. Am. J. Physiol. Cell Physiol.
3066, C585–C597. doi: 10.1152/ajpcell.00183.2013
Pawson, T., and Scott, J. D. (1997). Signaling through scaffold, anchoring, and
adaptor proteins. Science 2785346, 2075–2080. doi: 10.1126/science.278.5346.
2075
Pellagatti, A., Cazzola, M., Giagounidis, A., Perry, J., Malcovati, L., Della Porta,
M. G., et al. (2010). Deregulated gene expression pathways in myelodysplastic
Frontiers in Cell and Developmental Biology | www.frontiersin.org 12 April 2020 | Volume 8 | Article 165
fcell-08-00165 April 8, 2020 Time: 16:13 # 13
Baarsma et al. AKAP-PKA Interaction in Human ASM
syndrome hematopoietic stem cells. Leukemia 244, 756–764. doi: 10.1038/leu.
2010.31
Petrilli, A. M., and Fernández-Valle, C. (2016). Role of Merlin/NF2 inactivation in
tumor biology. Oncogene 355, 537–548. doi: 10.1038/onc.2015.125
Poppinga, W. J., Heijink, I. H., Holtzer, L. J., Skroblin, P., Klussmann, E., Halayko,
A. J., et al. (2015). A-kinase-anchoring proteins coordinate inflammatory
responses to cigarette smoke in airway smooth muscle. Am. J. Physiol. Lung
Cell. Mol. Physiol. 3088, L766–L775. doi: 10.1152/ajplung.00301.2014
Poppinga, W. J., Munoz-Llancao, P., Gonzalez-Billault, C., and Schmidt,
M. (2014). A-kinase anchoring proteins: cAMP compartmentalization in
neurodegenerative and obstructive pulmonary diseases. Br. J. Pharmacol. 17124,
5603–5623. doi: 10.1111/bph.12882
Qi, F., Yuan, Y., Zhi, X., Huang, Q., Chen, Y., Zhuang, W., et al. (2015). Synergistic
effects of AKAP95, cyclin D1, cyclin E1, and Cx43 in the development of rectal
cancer. Int. J. Clin. Exp. Pathol. 82, 1666–1673.
Ravenhall, C., Guida, E., Harris, T., Koutsoubos, V., and Stewart, A. (2000). The
importance of ERK activity in the regulation of cyclin D1 levels and DNA
synthesis in human cultured airway smooth muscle. Br. J. Pharmacol. 1311,
17–28. doi: 10.1038/sj.bjp.0703454
Rinaldi, L., Sepe, M., Donne, R. D., and Feliciello, A. (2015). A dynamic interface
between ubiquitylation and cAMP signaling. Front. Pharmacol. 6:177. doi: 10.
3389/fphar.2015.00177
Roscioni, S. S., Dekkers, B. G., Prins, A. G., Menzen, M. H., Meurs, H., Schmidt, M.,
et al. (2011a). cAMP inhibits modulation of airway smooth muscle phenotype
via the exchange protein activated by cAMP (Epac) and protein kinase A. Br. J.
Pharmacol. 1621, 193–209. doi: 10.1111/j.1476-5381.2010.01011.x
Roscioni, S. S., Maarsingh, H., Elzinga, C. R., Schuur, J., Menzen, M., Halayko,
A. J., et al. (2011b). Epac as a novel effector of airway smooth muscle relaxation.
J. Cell. Mol. Med. 157, 1551–1563. doi: 10.1111/j.1582-4934.2010.01150.x
Roscioni, S. S., Prins, A. G., Elzinga, C. R., Menzen, M. H., Dekkers, B. G., Halayko,
A. J., et al. (2011c). Protein kinase A and the exchange protein directly activated
by cAMP (Epac) modulate phenotype plasticity in human airway smooth
muscle. Br. J. Pharmacol. 1643, 958–969. doi: 10.1111/j.1476-5381.2011.01354.x
Schaafsma, D., McNeill, K. D., Stelmack, G. L., Gosens, R., Baarsma, H. A.,
Dekkers, B. G., et al. (2007). Insulin increases the expression of contractile
phenotypic markers in airway smooth muscle. Am. J. Physiol. Cell. Physiol. 2931,
C429–C439.
Scott, P. H., Belham, C. M., al-Hafidh, J., Chilvers, E. R., Peacock, A. J., Gould,
G. W., et al. (1996). A regulatory role for cAMP in phosphatidylinositol
3-kinase/p70 ribosomal S6 kinase-mediated DNA synthesis in platelet-derived-
growth-factor-stimulated bovine airway smooth-muscle cells. Biochem. J.
318(Pt 3), 965–971. doi: 10.1042/bj3180965
Simeone-Penney, M. C., Severgnini, M., Rozo, L., Takahashi, S., Cochran,
B. H., and Simon, A. R. (2008). PDGF-induced human airway smooth
muscle cell proliferation requires STAT3 and the small GTPase Rac1. Am. J.
Physiol. Lung Cell. Mol. Physiol. 2944, L698–L704. doi: 10.1152/ajplung.00529.
2007
Skroblin, P., Grossmann, S., Schafer, G., Rosenthal, W., and Klussmann, E. (2010).
Mechanisms of protein kinase A anchoring. Int. Rev. Cell. Mol. Biol. 283,
235–330. doi: 10.1016/S1937-6448(10)83005-9
Steen, R. L., Cubizolles, F., Le Guellec, K., and Collas, P. (2000). A kinase-anchoring
protein (AKAP)95 recruits human chromosome-associated protein (hCAP)-
D2/Eg7 for chromosome condensation in mitotic extract. J. Cell Biol. 1493,
531–536. doi: 10.1083/jcb.149.3.531
Stringer, D. K., and Piper, R. C. (2011). Terminating protein ubiquitination:
hasta la vista, ubiquitin. Cell Cycle 1018, 3067–3071. doi: 10.4161/cc.10.18.1
7191
Takuwa, N., Fukui, Y., and Takuwa, Y. (1999). Cyclin D1 expression mediated by
phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling
in growth factor-stimulated NIH 3T3 fibroblasts. Mol. Cell. Biol. 192, 1346–
1358. doi: 10.1128/mcb.19.2.1346
Tran, T., Teoh, C. M., Tam, J. K., Qiao, Y., Chin, C. Y., Chong, O. K., et al.
(2013). Laminin drives survival signals to promote a contractile smooth muscle
phenotype and airway hyperreactivity. FASEB J. 2710, 3991–4003. doi: 10.1096/
fj.12-221341
Vijayaraghavan, S., Goueli, S. A., Davey, M. P., and Carr, D. W. (1997). Protein
kinase A-anchoring inhibitor peptides arrest mammalian sperm motility. J. Biol.
Chem. 2728, 4747–4752. doi: 10.1074/jbc.272.8.4747
Withers, D. J., Seufferlein, T., Mann, D., Garcia, B., Jones, N., and Rozengurt,
E. (1997). Rapamycin dissociates p70(S6K) activation from DNA synthesis
stimulated by bombesin and insulin in Swiss 3T3 cells. J. Biol. Chem. 2724,
2509–2514. doi: 10.1074/jbc.272.4.2509
Wong, W., and Scott, J. D. (2004). AKAP signalling complexes: focal points in space
and time. Nat. Rev. Mol. Cell Biol. 512, 959–970. doi: 10.1038/nrm1527
Yin, H., Jiang, Y., Li, H., Li, J., Gui, Y., and Zheng, X. L. (2011). Proteasomal
degradation of myocardin is required for its transcriptional activity in vascular
smooth muscle cells. J. Cell. Physiol. 2267, 1897–1906. doi: 10.1002/jcp.2
2519
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Baarsma, Han, Poppinga, Driessen, Elzinga, Halayko, Meurs,
Maarsingh and Schmidt. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) and the
copyright owner(s) are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Cell and Developmental Biology | www.frontiersin.org 13 April 2020 | Volume 8 | Article 165
